antennal glomerulus & neuron | somatic clone
olfactory sensory organ & neuron & dendrite | somatic clone
Expressing vvldsRNA.UAS under the control of Scer\GAL4da.G32 in a vvldfr-B129 heterozygous background results in melanized spots in the cuticle, Malpighian tubules and gastric caecum, and abnormal morphology of the fat body in third instar larvae. Expressing vvldsRNA.UAS under the control of Scer\GAL4c729 in a vvldfr-B129 heterozygous background results in melanized tissues and death prior to eclosion.
In vvldfr-B129/+ embryos less than 2% of muscles 12 and 13 fail to be innervated and only 4% of ISNb axons leave the ventral muscle field and target the transverse nerve (TN) fascicle. In vvldsRNA.Scer\UAS, vvldfr-B129/+ embryos with Scer\GAL4Lim3.B or Scer\GAL4ftz.ng, ISNb motor axons leave the ventral muscle field and contact or target the transverse nerve (TN) fascicle. There is also an overall decrease in muscle innervation by ISNb motor axons in these embryos.
When homozygous somatic clones are made in the lateral projection neurons, no significant change is seen in cell numbers within clones. These clones do show a decrease in the number of lateral landmark glomeruli innervated. 8/10 lateral of the glomeruli are still innervated by clones, but VA4 is never innervated. DM5 is missing about half the time.
Tracheal structures are defective in homozygotes, although some tracheal tissue is present.
vvldfr-B129 has abnormal neuroanatomy | dominant phenotype, enhanceable by Lim3[+]/Lim36
Lim3[+]/Lim36, vvldfr-B129 has abnormal neuroanatomy | dominant phenotype, enhanceable by tupisl-1/tup[+]
tupisl-1/tup[+], vvldfr-B129 has abnormal neuroanatomy | dominant phenotype, enhanceable by Lim3[+]/Lim36
Lim36, vvl[+]/vvldfr-B129 has abnormal neuroanatomy | dominant phenotype, enhanceable by tupisl-1/tup[+]
tupisl-1, vvl[+]/vvldfr-B129 has abnormal neuroanatomy | dominant phenotype, enhanceable by Lim3[+]/Lim36
vvldfr-B129 has abnormal neuroanatomy | dominant phenotype, enhanceable by tupisl-1/tup[+]
vvldfr-B129 has abnormal neuroanatomy | dominant phenotype, enhanceable by Df(2L)E71/+
vvldfr-B129 has abnormal neuroanatomy | dominant phenotype, non-enhanceable by exex[+]/exexKK30
vvl[+]/vvldfr-B129 is an enhancer of abnormal neuroanatomy | dominant phenotype of Lim36
vvl[+]/vvldfr-B129 is an enhancer of abnormal neuroanatomy | dominant phenotype of tupisl-1
vvldfr-B129 has larval intersegmental nerve | embryonic stage 16 phenotype, enhanceable by Lim3[+]/Lim36
vvldfr-B129 has larval intersegmental nerve | embryonic stage 16 phenotype, enhanceable by Df(2L)E71/+
vvldfr-B129 has larval transverse nerve | embryonic stage 16 phenotype, enhanceable by Df(2L)E71/+
Lim3[+]/Lim36, vvldfr-B129 has larval intersegmental nerve | embryonic stage 16 phenotype, enhanceable by tupisl-1/tup[+]
tupisl-1/tup[+], vvldfr-B129 has larval intersegmental nerve | embryonic stage 16 phenotype, enhanceable by Lim3[+]/Lim36
vvldfr-B129 has larval transverse nerve | embryonic stage 16 phenotype, enhanceable by Lim3[+]/Lim36
Lim36, vvl[+]/vvldfr-B129 has larval intersegmental nerve | embryonic stage 16 phenotype, enhanceable by tupisl-1/tup[+]
tupisl-1, vvl[+]/vvldfr-B129 has larval intersegmental nerve | embryonic stage 16 phenotype, enhanceable by Lim3[+]/Lim36
vvldfr-B129 has larval intersegmental nerve | embryonic stage 16 phenotype, enhanceable by tupisl-1/tup[+]
vvldfr-B129 has larval transverse nerve | embryonic stage 16 phenotype, enhanceable by tupisl-1/tup[+]
vvldfr-B129 has larval intersegmental nerve | embryonic stage 16 phenotype, non-enhanceable by exex[+]/exexKK30
vvldfr-B129 has larval transverse nerve | embryonic stage 16 phenotype, non-enhanceable by exex[+]/exexKK30
vvl[+]/vvldfr-B129 is an enhancer of larval intersegmental nerve | embryonic stage 16 phenotype of Lim36
vvl[+]/vvldfr-B129 is an enhancer of larval transverse nerve | embryonic stage 16 phenotype of Lim36
vvl[+]/vvldfr-B129 is an enhancer of larval intersegmental nerve | embryonic stage 16 phenotype of tupisl-1
vvl[+]/vvldfr-B129 is an enhancer of larval transverse nerve | embryonic stage 16 phenotype of tupisl-1
In vvldfr-B129/+ embryos less than 2% of muscles 12 and 13 fail to be innervated and only 4% of ISNb axons leave the ventral muscle field and target the transverse nerve (TN) fascicle. The expressivity of these phenotypes is enhanced to 22% and 16.5% respectively by Df(2L)E71/+, to 21% and 16% respectively by tupisl-1/+ and to 29% and 24% respectively by Lim36/+. These phenotypes are not enhanced by exexKK30/+. In tupisl-1, Lim36/+; vvldfr-B129/+ embryos, the ISNb motoneurons fail to project to and innervate their specific target muscles, including muscles 12 and 13.
Complements: sinu06524.